SEC Form D · filed October 6, 2011
Revance Therapeutics, Inc
Offering
$1.2M
Sold
—
Exemption
—
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—
People & firms on this filing (8)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗